Board of Directors

Emmanuel Blin is the founder and CEO of Tech Care for All (TC4A), a social impact company aiming to accelerate digital health in Africa and Asia created in 2017. Previously, he spent 20 years in the pharmaceutical industry. He is a former member of the Executive Committee of Bristol-Myers Squibb, where he was Chief Strategy Officer and Co-Commercialization Director, after a series of assignments leading national and regional operations in Europe, Asia and the Americas. Mr Blin is President of Aignostics, a Berlin-based company specialising in artificial intelligence in oncology. He is a graduate of ESSEC in Paris and has completed the INSEAD-CEDEP general management programme.

Elizabeth Bastoni is an experienced Board Chair and executive with expertise in human resources, governance, strategy, risk and talent management. She is currently Chair of the Board of Directors of Limead, as well as member of the Board of Directors of Jeronimo Martins and BIC. Elizabeth began her career in international taxation at KPMG in Europe. She then held several executive positions with international groups such as The Coca-Cola Company, Carlson or Thalès.

Cécile Dussart is Vice President, Head of Global Operations of Galderma a Global Specialty pharma company and leader in the Dermatology field. Cécile builds and deploys the strategic road map for Operations driven by Galderma’s transformation program, as well as ensuring a professional and safe culture. She joined Galderma in 2005 as Human Resources Director for Industrial Operations, later becoming Plant Director at the Alby-sur-Chéran production facility in France in 2008. Prior to her roles at Galderma, Cécile was at Roche for more than eight years, where she held positions as Global Brand Manager and then Human Resources Business Partner. She began her career as a Brand Manager at Sanofi in 1990. Cécile studied pharmacy at the University of Paris XI and holds a master’s degree in marketing from ESCP Europe.

Claire Giraut is member of the board and Chair of the Development and Innovation Committee of Julius Baer. She was Member of the Board and Chair of the Audit Committee at DBV Technologies. Claire Giraut has held responsibilities in finance for most of her professional career. She was Chief Financial Officer and IS Officer at BioMérieux (2013-2018), Chief Financial Officer of Europcar Group (2011-2012) and of Ipsen (2003-2011) where she managed the company’s IPO. She began her career by holding various positions, particularly in finance, within the Sanders group. Claire is an agronomy engineer and is a graduate of the Institut National Agronomique in Paris.

Olivier Klaric is the Group Treasurer of Sanofi, overseeing the company’s Financing, Treasury, and Insurance operations.

His career in finance began in the banking sector in 1987, where he honed his skills across various international banks including Banco Europeo para America Latina (BEAL), Generale Bank, Mitsui Trust Bank Europe, and Banco Santander. His early experience laid a strong foundation for his expertise in financial operations and international finance.

He transitioned to Corporate Finance when he joined Alstom, where he played a pivotal role in the strategic debt restructuring of the group. Upon moving to Mittal Steel, as Treasurer he has been instrumental in the financing of the takeover of Arcelor, paving the way for the creation of ArcelorMittal. 

Géraldine Leveau has been appointed Deputy Secretary General for Investment in 2021 by the French Prime Minister. She is co-piloting France 2030, a €54 billion plan to promote innovation and reindustrialization.

Previously, she was Advisor to the French Minister of Higher Education, Research and Innovation, and Head of the Office of Innovation Ecosystems at the Ministry of Economy and Finance.

A French citizen, Géraldine Leveau holds a master's degree in political administration from Université Paris 1 Panthéon-Sorbonne.

Jean-Yves Caminade is the Chief Financial Officer at Bpifrance SA. He joined the group in 2005 through its development banking activities (formerly OSEO).

A graduate of HEC Paris, he began his career in strategy consulting at AT Kearney before joining Société Générale Asset Management (now Amundi) as a financial analyst. He then moved to the rating agency Moody’s.

Jean-Yves has also taught finance at Sciences Po Paris.

Mattias Perjos is currently President and Chief Executive Officer of Getinge, a listed company on the Stockholm Stock Exchange, which he joined in 2017. He previously held the CEO position at Coesia IPS Division and Coesia International (2012-2017). Prior to that, Mattias Perjos was CEO of Flexlink (2006-2016) and held other leading roles within the group which he joined in 1998. A Swedish citizen, Mattias Perjos holds a Master of Science in Industrial Engineering and Management.

Rodolfo Savitzky is Chief Financial Officer and member of the Executive Board of SoftwareONE. 

After serving as Finance Director at Procter & Gamble for the Beverage Division in Europe and then for the Beauty Care Division in Latin America, he joined Novartis in 2002 in the Pharmaceutical Division, first as Head of Finance for the Ophthalmic Business Unit and then as Head of Business Planning and Analysis followed by Head of Strategic Planning and Analysis for the Pharmaceutical Division. He was appointed CFO for Novartis Animal Health in 2006.  Rodolfo joined Lonza in 2015 where he became Chief Financial Officer and member of the Executive Board in 2016.  He was also a Non-Executive Director and Chairman of the Audit Committee of Unilabs in 2021.

Rodolfo Savitzky holds a bachelor’s degree in Industrial and Systems Engineering from the Monterrey Institute of Technology (ITESM) in Mexico, as well as an MBA from the University of Chicago (Booth School of Business) in the United States. 

Marie-Isabelle Penet is currently Global Senior Process Manager at EUROAPI and has a deep knowledge of process engineering.

She began her career at the Centre National de la Recherche Scientifique (CNRS-French National Centre for Scientific Research) before moving to Altran as an engineer. She then became laboratory head at Rhône-Poulenc before taking roles of increasing responsibilities at Sanofi.

Marie-Isabelle Penet is an engineer in Chemical Engineering by training (ENSIC school) and holds a PhD in Fluid Mechanic. She is also certified in project economic assessment and as such a member of the Société Française pour l'avancement du Management de Projet (French Society for the Advancement of Project Management). She is a member of the board of the Advanced Process Engineering commission of the Société Française de Génie des Procédés (SFGP-French Society of Process Engineering).

Kevin Rodier is currently the HSE QT correspondent at the “120” workshop in EUROAPI Vertolaye (Puy-de-Dôme), a site where he has 16 years' seniority.

After a year spent in the "Operational Excellence" department, he returned to the "Production" department. Kevin Rodier began his career as a production technician before becoming a supervisor in various workshops.

He holds a Brevet de Technicien Supérieur (BTS) in chemistry.